Latest Market Research Updates

Medical Robotic Systems Market Is Expected To Reach $17.89 Billion By 2022

The Global medical robotic systems market revenue is expected to reach USD 17.89 billion by 2022, according to a new report by Grand View Research, Inc. Key drivers of this market include the increasing demand for robotic surgeries, constant improvement in healthcare infrastructure in emerging economies, improving reimbursement policies and increasing awareness levels amongst healthcare establishments, and practitioners.

According to data published by the U.S. FDA in 2012, approximately 450,000 robotic assisted surgeries were performed. The increase in prevalence of cancer, neurological disorders, spinal disorders, and prostate disorders are expected to further propel the demand for minimally invasive surgeries and consequently boost market growth.

To request a sample copy or view summary of this report, click the link below:
http://www.grandviewresearch.com/industry-analysis/medical-robotic-systems-market

Further key findings from the study suggest:

The introduction of new generation robotic systems integrated with advanced data recorders, remote navigation systems, HD microscopic cameras, data analytic systems, motion sensors; 3D-Imaging and robotic controlled catheters are further expected to boost demand over the forecast period
Surgical robots was the largest product segment at over 60.0% in 2014, owing to the increasing number of robotic surgeries performed and increase in patient acceptance pertaining to assisted minimally invasive surgeries.
Non medical hospital robotic systems are identified as the fastest growing product segment. Key factors accounting for this rapid growth include growing interest in telemedicine robots and cart robots which improve the automation in the hospital sector and also improve the patient care.
On the basis of application, laparoscopy enabled systems accounted for the largest revenue share at 80.0% in 2014. Increase in geriatric population and rise in the prevalence of neurological disorders such as brain tumors, strokes, and spinal disorders are some factors expected to drive segment growth over the forecast period.
In 2014, North America was the largest regional market with revenue share valued at over 40% owing to, the presence of advanced healthcare infrastructure, increasing demand for robot assisted surgeries, better reimbursement policies and the increasing geriatric population.
Asia Pacific market is the most lucrative in terms of future growth. The presence of high unmet medical needs, growth in public and private healthcare investment, improving reimbursement framework, and the increasing healthcare expenditure levels.
The global industry share is majorly dominated by companies such as Intuitive Surgical Inc., Mazor Robotics and Hansen.
Other players like Accuray, S.R.L, Health robotics Varian, Reninshaw Plc. have developed products and applications catering to certain niche areas to establish market domination.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
For More Information: www.grandviewresearch.com

Molecular Cytogenetics Market Is Projected To Reach $3.8 Billion By 2025

The global molecular cytogenetics market size is expected to reach USD 3. 8 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a 10.4% CAGR during the forecast period. Mapping of human genome, coupled with continuous technological advancements in cytogenetic techniques, has enabled researchers to gain insight into the disease-causing mechanism at a genomic as well as cellular level. Development in molecular technologies has helped in bridging the gap between molecular biology and cytogenetics, which was not possible using conventional cytogenetic techniques.

There is a continuous growth in awareness, and consequent adoption, of genetic tests for disease prognosis. These tests also help in designing further treatment regimes for widespread chromosomal abnormalities. This is sure to boost market growth.

Incorporation of high throughput sequencers in cytogenetic analysis is expected to significantly enhance market growth in the coming years. A number of researchers and scientists have begun converging cytogenetics laboratories with NGS as they complement each other. Hence, with exponential decline in sequencing price, this market is expected to grow at a lucrative pace.

However, ambiguous regulatory and reimbursement scenario in certain regions pertaining to implementation of genetic tests is expected to hamper the adoption of molecular cytogenetic techniques to a certain extent.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/molecular-cytogenetics-market

Further key findings from the report suggest:

Oncology held the largest share in the market in 2016 owing to the ability of CGH technology to facilitate in-depth studies for cancer etiology
Use of molecular cytogenetics in personalized medicine development is expected to grow lucratively during the forecast period. This is majorly due to a continuous shift toward targeted therapies for effective disease management
Requirement of consumables in the entire cytogenetics process is attributive for the largest share of this product category
Ongoing research projects for developing treatment regimen of different genetic conditions have allowed clinical and research laboratories to gain a significant share in the market
Pharmaceutical and biotech companies are expected to be a key source of revenue in the coming years. This is mainly because a number of pharmaceutical companies have expanded their business in the field of personalized medicine
Illumina, Inc.; Agilent Technologies, Inc.; Abbott; Bio-Rad Laboratories, Inc.; and Oxford Gene Technology are some prominent companies in the market. They are involved in development and commercialization of cytogenetics techniques
Some major service providers are Weill Cornell Medicine; WiCell Research Institute, Inc.; ARUP Laboratories; and Integrated Systems Engineering S.r.l.

About Grand View Research

Artificial Pancreas Device System Market Is Poised To Reach $390.4 Million By 2024

The global artificial pancreas device system market is anticipated to reach USD 390.4 million by 2024, according to a new report by Grand View Research, Inc. Increasing prevalence of diabetes, intensive R&D efforts by industry players, and rising demand for automated systems for glycemic control are the key factors that are driving the market growth.

Regulatory bodies such as FDA are continuously approving new and innovative products which is increasing the reach of the companies in various market. For instance, in December 2016, OneTouch Vibe plus Insulin Pump by Animas received FDA approval and Health Canada License for the sale of the product. In January 2016, Animas received FDA approval for Animas Vibe Insulin Pump, the device to manage of diabetes in children and adolescents.

Similarly, in June 2016, Tandem Diabetes Care cleared its FDA approval for remote software update tool for insulin pump. Also, in September 2016, the company received FDA approval for their product t:slim G4 Insulin Pump giving the diabetes community a powerful new tool to help simplify therapy managementSuch factors are contributing to the growth of the market.

Additionally, the prevalence of diabetes is increasing in low and middle-income counties owing to the sedentary lifestyle, genetic modification, obesity, lack of physical activity, and unhealthy diet. According to the data published by the International Diabetes Federation(IDF), in 2015 there were about 415 million people suffering from diabetes globally. Also, Based on the information provided by the American Diabetes Association, in 2012, about 29.1 million Americans suffered from diabetes out of which 90% were of type2 and 1.25 million suffered from type 1 diabetes. Furthermore, the increasing dependency of type 2 diabetes on insulin is expected to create opportunities for the artificial pancreas devices market.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/artificial-pancreas-device-market

Further Key Findings From the Study Suggest:

Control to Target (CTT) systems is anticipated to witness fastest growth during the forecast period as they are fully automated and require no intervention on the patient’s part for the administration of insulin or for the monitoring of glucose levels.
Asia Pacific artificial pancreas device system market is expected to grow with the highest CAGR over the forecast period owing to the lifestyle, genetic modification, urbanization and aging population.
Major players of the market include, Medtronic Plc, Bigfoot Biomedical, Johnson & Johnson, Tandem Diabetes Care, Inc., Pancreum, Inc., TypeZero Technologies, LLC, and Beta Bionics.

About Grand View Research

Life Science Analytics Market Is Projected To Reach $25.9 Billion By 2025

The global life science analytics market size is expected to reach USD 25.9 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 12.9% during the forecast period. Increasing digitalization in pharma and life sciences industry to improve its value chain is one of the key factors anticipated to boost the market over the forecast period. In addition, reducing R&D productivity and increasing regulatory oversights are some of the factors expected to drive this market.

Rising healthcare cost is one of the crucial factors anticipated to positively impact the life science analytics market. Developing as well as developed regions are facing many challenges in providing cost-effective and qualitative care. According to various reports, approximately 70.0% of the geriatric population is expected to use some kind of long-term care during their lifetime. Based on the abovementioned scenario in 2017, on an average, a retired couple is anticipated to spend over USD 275,000 in healthcare throughout their lifetime. Moreover, political instability, economic stress, and lack of proactive initiatives may result in low healthcare funding.

Some of the key factors anticipated to boost global healthcare cost are growing number of claims pertaining to non-communicable diseases, priority for wellness at workplaces, and growing focus on wellness among adult and geriatric population. Growing healthcare cost is expected to boost demand for life science analytics to streamline third-party processes and optimize overall cost.

Adoption of big data analytics in the life sciences industry allows government and healthcare providers to identify high-risk population for preventive care measures and compare effective treatment procedures to evaluate relative cost of care, thereby reducing overall cost and improving quality of care. For instance, in 2011, the Arkansas Healthcare Payment Improvement Initiative (AHCPII) saved nearly USD 720 million while expanding its coverage to uninsured individuals in U.S.

Advanced methods such as predictive analytics are widely used in healthcare financing systems primarily to avoid frauds in payments. For instance, in 2011, CMS reported that under its Fraud Prevention System (FPS), predictive analytics helped save USD 1.5 billion by preventing frauds and improper payments. Moreover, CMS is developing next-generation predictive analytics, which is expected to boost its usage across applications.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/life-science-analytics-market

Further key findings from the report suggest:

As of 2016, reporting was most widely used type and thus held nearly 30.0% share in the global market
In 2016, sales and marketing support held the largest share in the global market owing to higher adoption of analytics in the life sciences industry for sales activities
Some of the key players operating in this market are Accenture; Cognizant; IBM Corporation; Oracle; SAS Institute, Inc.; Wipro Limited; IQVIA; and TAKE Solutions Limited.

About Grand View Research

Drug Discovery Informatics Market Is Projected To Reach $2.07 Billion By 2025

The global drug discovery informatics market size is expected to reach USD 2.07 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 12.6% during the forecast period. Drug therapy is evolving in response to health care needs of the population. The most recent trend is to develop drugs for treatment of chronic diseases, especially those affecting the older population.

Cardiovascular Diseases (CVDs), stroke, and cancer are the most prevalent health issues and also the most common conditions causing death. Moreover, treatment expenses and costs pertaining to these diseases are very high, which triggers the demand for effective novel molecules. In the U.S. alone, revenue generated through CVD treatments was over USD 444 billion in 2010, and it has been estimated to claim more lives each year than the remaining causes of death combined.

Clinical decision support tools, which include online database for assistance in enhancement of clinical decisions, are timely updated and that significantly impacts market growth. Moreover, the World Health Organization's Consultative Expert Working Group for Research and Development is also involved in evaluation and development of open source drug discovery platforms. Introduction of open drug discovery tool kit (ODDT), which serves as a tool for computer-aided drug discovery by implementing machine learning scoring functions (RF-Score and NN-Score), is anticipated to work in favor of the market.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/drug-discovery-informatics-market

Further key findings from the report suggest:

Lead generation and lead optimization are anticipated to witness hand-in-hand growth owing to usage of similar IT solutions
Presence of different co-operation models, such as joint ventures, strategic partnership, price competition, and project selection, for outsourcing drug informatics solutions in the industry is influencing the growth of the market positively
North America is projected to hold prominent position in the arena throughout the forecast period. Higher incidence rates of different infectious diseases and oncology diseases are expected to drive the demand for informatics solutions to aid drug discovery and development. Presence of molecular R&D laboratories and market players in the U.S. is supplementing the growth of the regional market
Asia Pacific is likely to post the highest CAGR during the same period, owing to cost saving advantage offered by the region
Some of the key players operating in the market Boehringer Ingelheim GmBh; ChemAxon; Jubilant Biosys; Certara; Selvita; Novo Informatics; Albany Molecular Research Inc.; Infosys; DiscoverX; Collaborative Drug Discovery Inc; GVK Biosciences; and Charles River Laboratories.

About Grand View Research

Brain Implants Market Is Poised To Reach $8.29 Billion By 2025

The global brain implants market size is anticipated to reach USD 8.29 billion by 2025, according to a new report by Grand View Research, Inc., rising at a CAGR of 11.9% during the forecast period. Mounting cases of neurological disorders such as Parkinson’s, Alzheimer’s, epilepsy, depression, and tremors are contributing to market growth.

Growing incidence of Parkinson’s disease is boosting the demand for brain implants. These implants help in improving body movement and reduce the need for drugs. According to statistics presented by Parkinson’s News Today, about 10 million people suffer from this disease globally. Cases of epilepsy are also increasing due to brain injuries, stroke, and unhealthy lifestyle. As per statistics by Forbes, nearly 3 million people were affected with epilepsy in U.S. in 2017. Demand for vagus nerve stimulators is on a sharp rise owing to its treatment benefits for epilepsy.

In addition, factors such as technological advancements in brain implants, along with rising disposable income in developed countries, are propelling market growth. The market is expected to witness lucrative growth over the coming years as a consequence of increasing number of research activities leading to technological breakthroughs. These include self-charging implants and memory chips, which are estimated to unfold tremendous growth opportunities over the forecast period.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/brain-implants-market

Further key findings from the study suggest:

In 2016, the deep brain stimulator segment was identified as the largest, accounting for over 37.0% of the overall market revenue. The product is projected to maintain its position over the forecast period due to rising incidence of Parkinson’s disease
The Parkinson’s disease segment is poised to expand at the fastest growth rate in terms of revenue during the same period owing to factors such as drop in smoking rate and coffee consumption, particularly in developed countries
Demand for brain implants will remain the highest for treatment of chronic pains throughout the forecast period, representing approximately 58.0% of the overall market revenue by 2025
The Asia Pacific brain implants market is likely to exhibit the highest CAGR of over 13.0% over the same period, owing to rising healthcare spending and disposable income of the populace in countries such as Japan and China
Boston Scientific; Medtronic; St. Jude Medical; Nevro Corporation; NeuroPace Inc.; and NDI Medical LLC are some of the key players in the brain implants market.

About Grand View Research

Medical Image Analysis Software Market Is Estimated To Reach $4.51 Billion By 2024

The global medical image analysis software market size is expected to reach USD 4.51 billion by 2024, according to a new report by Grand View Research, Inc., registering an 8.1% CAGR during the forecast period. Increasing incidence of chronic diseases creates demand for effective diagnostics solutions, which spurs demand for medical image analysis software. High growth of the industry is majorly attributed to increase in usage and uptake of image analysis solutions for diagnosis.

In addition, shifting focus to provide enhanced care has led to incorporation of various computer aided diagnosis systems, which is further contributing toward growth. Introduction of technologically advanced products such as 3D/4D platforms and multimodality imaging platforms is also presumed to augment growth over the coming years.

Various benefits such as flexibility and high-resolution images, along with convenient use of multi-modal integrated workflows, are expected to bolster demand and increase product penetration throughout the forecast period. Stand-alone platforms are anticipated to witness steady growth. These platforms are user-friendly and cost less as compared to integrated solutions. These solutions offer more details and features and are used by researchers, allowing them to share and access research data and analyses, thereby enhancing their ability to diagnose, research, monitor, and treat disorders. For instance, GE healthcare’s ViewPoint 6 (for MFM) is a standalone software designed for dedicated ultrasound reporting and image management.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-image-analysis-software-market

Further key findings from the report suggest:

By type, the integrated medical image analysis software segment is anticipated to expand at a CAGR of 7.8% from 2016 to 2024
On the basis of modality, the ultrasound segment is projected to ascend at a revenue-based CAGR of 10.5% over the forecast period
The orthopedic segment dominated the global market by application, accounting for over 40.0% share in 2015
By end use, hospitals held the largest revenue share owing to increasing adoption of these systems for medical imaging in diagnosis of various diseases
Asia Pacific is expected to show significant growth owing to presence of unmet clinical needs
The global market is fragmented in nature. Companies are witness fierce competition as the industry is technology driven
Strategies implemented by key players include collaborative agreements, new product launches, and geographical expansion.

About Grand View Research

Latest Market Research Updates

Medical Robotic Systems Market Is Expected To Reach $17.89 Billion By 2022

Molecular Cytogenetics Market Is Projected To Reach $3.8 Billion By 2025

Artificial Pancreas Device System Market Is Poised To Reach $390.4 Million By 2024

Life Science Analytics Market Is Projected To Reach $25.9 Billion By 2025

Drug Discovery Informatics Market Is Projected To Reach $2.07 Billion By 2025

Brain Implants Market Is Poised To Reach $8.29 Billion By 2025

Medical Image Analysis Software Market Is Estimated To Reach $4.51 Billion By 2024

mHealth Apps Market Is Projected To Reach $236.0 Billion By 2026

Report Abuse

Labels